| Product Code: ETC10600402 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Human Immunodeficiency Virus Type Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Human Immunodeficiency Virus Type Market - Industry Life Cycle |
3.4 Japan Human Immunodeficiency Virus Type Market - Porter's Five Forces |
3.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Japan Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
3.7 Japan Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.8 Japan Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Japan Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Goals, 2021 & 2031F |
4 Japan Human Immunodeficiency Virus Type Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV/AIDS in Japan |
4.2.2 Technological advancements in HIV diagnostic tools and treatment options |
4.2.3 Government initiatives and funding for HIV prevention and treatment programs |
4.3 Market Restraints |
4.3.1 Stigma and discrimination associated with HIV/AIDS in Japanese society |
4.3.2 High cost of HIV treatment and medications |
4.3.3 Limited access to healthcare services for marginalized populations |
5 Japan Human Immunodeficiency Virus Type Market Trends |
6 Japan Human Immunodeficiency Virus Type Market, By Types |
6.1 Japan Human Immunodeficiency Virus Type Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Antiretroviral Therapy, 2021 - 2031F |
6.1.4 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.1.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.1.6 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F |
6.2 Japan Human Immunodeficiency Virus Type Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.2.3 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Integrase Strand Transfer Inhibitors, 2021 - 2031F |
6.2.4 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.2.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Japan Human Immunodeficiency Virus Type Market, By Delivery Method |
6.3.1 Overview and Analysis |
6.3.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.4 Japan Human Immunodeficiency Virus Type Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-Positive Adults, 2021 - 2031F |
6.4.3 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By High-Risk Populations, 2021 - 2031F |
6.4.4 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Healthcare Workers, 2021 - 2031F |
6.4.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Pregnant Women, 2021 - 2031F |
6.5 Japan Human Immunodeficiency Virus Type Market, By Treatment Goals |
6.5.1 Overview and Analysis |
6.5.2 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.3 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-Exposure Prevention, 2021 - 2031F |
6.5.5 Japan Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-1 Transmission Prevention, 2021 - 2031F |
7 Japan Human Immunodeficiency Virus Type Market Import-Export Trade Statistics |
7.1 Japan Human Immunodeficiency Virus Type Market Export to Major Countries |
7.2 Japan Human Immunodeficiency Virus Type Market Imports from Major Countries |
8 Japan Human Immunodeficiency Virus Type Market Key Performance Indicators |
8.1 Number of individuals tested for HIV annually in Japan |
8.2 Percentage of diagnosed HIV cases receiving timely treatment |
8.3 Rate of new HIV infections in Japan |
8.4 HIV/AIDS-related mortality rate in Japan |
8.5 Level of public and private investment in HIV prevention and treatment programs |
9 Japan Human Immunodeficiency Virus Type Market - Opportunity Assessment |
9.1 Japan Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Japan Human Immunodeficiency Virus Type Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
9.3 Japan Human Immunodeficiency Virus Type Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.4 Japan Human Immunodeficiency Virus Type Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Japan Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Goals, 2021 & 2031F |
10 Japan Human Immunodeficiency Virus Type Market - Competitive Landscape |
10.1 Japan Human Immunodeficiency Virus Type Market Revenue Share, By Companies, 2024 |
10.2 Japan Human Immunodeficiency Virus Type Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here